Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP)
Endocrinology and Metabolism · 2025
DOI: 10.3803/enm.2024.2136 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Endocrinology and Metabolism, 2025. Verfasst von Jae Hoon Moon und 36 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Carcinoma, Papillary, Thyroid Neoplasms, Watchful Waiting. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health and Welfare.
Abstract (Originalsprache)
Background
Active surveillance (AS) has emerged as a viable management strategy for low-risk papillary thyroid microcarcinoma (PTMC), following pioneering trials at Kuma Hospital and the Cancer Institute Hospital in Japan. Numerous prospective cohort studies have since validated AS as a management option for low-risk PTMC, leading to its inclusion in thyroid cancer guidelines across various countries. From 2016 to 2020, the Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) enrolled 1,177 patients, providing comprehensive data on PTMC progression, sonographic predictors of progression, quality of life, surgical outcomes, and cost-effectiveness when comparing AS to immediate surgery. The second phase of MAeSTro (MAeSTro-EXP) expands AS to low-risk papillary thyroid carcinoma (PTC) tumors larger than 1 cm, driven by the hypothesis that overall risk assessment outweighs absolute tumor size in surgical decision-making.
Methods
This protocol aims to address whether limiting AS to tumors smaller than 1 cm may result in unnecessary surgeries for low-risk PTCs detected during their rapid initial growth phase. By expanding the AS criteria to include tumors up to 1.5 cm, while simultaneously refining and standardizing the criteria for risk assessment and disease progression, we aim to minimize overtreatment and maintain rigorous monitoring to improve patient outcomes.
Conclusion
This study will contribute to optimizing AS guidelines and enhance our understanding of the natural course and appropriate management of low-risk PTCs. Additionally, MAeSTro-EXP involves a multinational collaboration between South Korea and Australia. This cross-country study aims to identify cultural and racial differences in the management of low-risk PTC, thereby enriching the global understanding of AS practices and their applicability across diverse populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Department of Internal Medicine, National Cancer Center, Goyang, Korea.
- Center for Thyroid Cancer, National Cancer Center, Goyang, Korea.
- Department of Otorhinolaryngology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Förderung
- Ministry of Health and Welfare
Zitieren
APA
Moon, J. H., Lee, E. K., Cha, W., Chai, Y. J., Cho, S. W., Choi, J. Y., Choi, S. Y., Chu, A. J., Chung, E. J., Hwangbo, Y., Jeong, W. J., Jung, Y. S., Kim, K., Kim, M. J., Kim, S. J., Kim, W., Kim, Y. H., Lee, C. Y., Lee, J. Y., …, & Park, Y. J. (2025). Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP). Endocrinology and Metabolism. https://doi.org/10.3803/enm.2024.2136
Vancouver
Moon JH, Lee EK, Cha W, Chai YJ, Cho SW, Choi JY, et al. Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP). Endocrinology and Metabolism. 2025. doi:10.3803/enm.2024.2136
BibTeX
@article{Moon2025,
author = {Moon, Jae Hoon and Lee, Eun Kyung and Cha, Wonjae and Chai, Young Jun and Cho, Sun Wook and Choi, June Young and Choi, Sung Yong and Chu, A Jung and Chung, Eun-Jae and Hwangbo, Yul and Jeong, Woo-Jin and Jung, Yuh-Seog and Kim, Kyungsik and Kim, Min Joo and Kim, Su-Jin and Kim, Woochul and Kim, Yoo Hyung and Lee, Chang Yoon and Lee, Ji Ye and Lee, Kyu Eun and Lee, Young Ki and Lim, Hunjong and Park, Do Joon and Park, Sue K and Ryu, Chang Hwan and Ryu, Junsun and Seok, Jungirl and Song, Young Shin and Yi, Ka Hee and Yu, Hyeong Won and White, Eleanor and Mastrocostas, Katerina and Clifton-Bligh, Roderick J and Glover, Anthony and Gild, Matti L and Kim, Ji-Hoon and Park, Young Joo},
title = {Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP)},
journal = {Endocrinology and Metabolism},
year = {2025},
doi = {10.3803/enm.2024.2136}
}
EUVIMED